10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001121781-15-000121`
Period End Date	20150331
Filing Date	20150513
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	gthp-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 40 Cash Flow Statement 62

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$76.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$76.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $76 at March 31, 2015 and December 31, 2014	`AccountsReceivableNet`	$338.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $76 at March 31, 2015 and December 31, 2014	`AccountsReceivableNet`	$358.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$133.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$144.00K	USD	Point-in-time
Inventory, net of reserves of $133 and $144, at March 31, 2015 and December 31, 2014, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.15M	USD	Point-in-time
Inventory, net of reserves of $133 and $144, at March 31, 2015 and December 31, 2014, respectively	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$1.18M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$52.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$99.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.58M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.78M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$515.00K	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$587.00K	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	1.20	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$93.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	1.20	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$101.00K	USD	Point-in-time
Debt issuance cost	`DeferredFinanceCostsNet`	$564.00K	USD	Point-in-time
Debt issuance cost	`DeferredFinanceCostsNet`	$375.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	195,000.00	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	195,000.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.25M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$983.00K	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	100,055.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.03M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.56M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	100,055.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	96,889.00	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$646.00K	USD	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$648.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$123.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$168.00K	USD	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	$1.24M	USD	Point-in-time
Short-term notes payable, net of discount	`NotesAndLoansPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.73M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.01M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.52M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$24.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$24.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.60M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.07M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.36M	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	$40.00K	USD	Point-in-time
Long-term debt, net	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$795.00K	USD	Point-in-time
Convertible Debt, net of discount	`ConvertibleLongTermNotesPayable`	$783.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$262.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.89M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$2.41M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.58M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$7.50M	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 1.2 shares issued and outstanding as of March 31, 2015 and December 31, 2014, (Liquidation preference of $1,200 at March 31, 2015 and December 31, 2014)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3 shares authorized, 1.2 shares issued and outstanding as of March 31, 2015 and December 31, 2014, (Liquidation preference of $1,200 at March 31, 2015 and December 31, 2014)	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$678.00K	USD	Point-in-time
Common stock, $.001 Par value; 195,000 shares authorized, 100,055 and 96,889 shares issued and outstanding as of March, 31 2015 and December 31, 2014	`CommonStockValue`	$99.00K	USD	Point-in-time
Common stock, $.001 Par value; 195,000 shares authorized, 100,055 and 96,889 shares issued and outstanding as of March, 31 2015 and December 31, 2014	`CommonStockValue`	$97.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$107.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$108.67M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-113.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-114.34M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.46M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.02M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.03M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.56M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$122.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$127.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$192.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$107.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-70.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$20.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$19.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$15.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$607.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$373.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$172.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$283.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$963.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.14M	USD	1 Quarter
Total	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total	`OperatingExpenses`	$2.03M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.47M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.08M	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$6.00K	USD	1 Quarter
OTHER INCOME	`OtherIncome`	$2.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$492.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$27.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$542.00K	USD	1 Quarter
CHANGES IN FAIR VALUE OF WARRANTS	`DerivativeGainLossOnDerivativeNet`	$714.00K	USD	1 Quarter
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$228.00K	USD	1 Quarter
TOTAL OTHER INCOME	`OtherNonoperatingIncome`	$517.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.56M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.25M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.25M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.56M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-31.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-48.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.61M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.28M	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	97,324.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	71,451.00	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.56M	USD	1 Quarter
Depreciation	`Depreciation`	$117.00K	USD	1 Quarter
Depreciation	`Depreciation`	$72.00K	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	-	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$402.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$359.00K	USD	1 Quarter
Stock based compensation	`ShareBasedCompensation`	$192.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-541.00K	USD	1 Quarter
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$-714.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$20.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$61.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-31.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-47.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-53.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-41.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-8.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$377.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-169.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-8.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$255.00K	USD	1 Quarter
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$508.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$262.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$603.00K	USD	1 Quarter
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$619.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-626.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-959.00K	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	1 Quarter
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$451.00K	USD	1 Quarter
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfLongTermDebt`	$378.00K	USD	1 Quarter
Proceeds from debt financing	`ProceedsFromIssuanceOfLongTermDebt`	$62.00K	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$31.00K	USD	1 Quarter
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$45.00K	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$67.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$482.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$400.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-144.00K	USD	1 Quarter
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-563.00K	USD	1 Quarter
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$18.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$613.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$50.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$8.00K	USD	1 Quarter
Cash paid for Interest	`InterestPaid`	$22.00K	USD	1 Quarter
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	1 Quarter
Conversion of accrued expenses into common stock / options	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$22.00K	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$31.00K	USD	1 Quarter
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	-	USD	1 Quarter
Dividends on preferred stock	`DeemedDividendsOnPreferredStock`	-	USD	1 Quarter
Dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$50.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.